PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
November 9, 2001Journal of Medicinal Chemistry127 citations

Design, Synthesis, and Biological Activity of a Novel Non-Cisplatin-type Platinum−Acridine Pharmacophore

View Full Paper
EMElizabeth T. MartinsHBHemanta BaruahJKJaroslaw Kramarczyk

Key Points

Key points are not available for this paper at this time.

Abstract

Platinum-acridine conjugates were prepared from PtCl2(ethane-1,2-diamine) and the novel acridinylthioureas MeHNC(S)NMeAcr (6) and MeHNC(S)NMe(CH2CH2)NHAcr (15) by replacing one chloro leaving group in the cisplatin analogue with thiourea sulfur. In HL-60 leukemia cells, IC(50) values for 7 (Pt-tethered 6) and 16 (Pt-tethered 15) were 75 and 0.13 microM, respectively. In the ovarian cell lines 2008 and C13, 16 was active at micromolar concentrations and showed only partial cross-resistance with clinical cisplatin. Possible structure-activity relationships are discussed.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Martins et al. (2001) studied this question.

synapsesocial.com/papers/6a69f382c709c350d6e86e53https://doi.org/10.1021/jm010293m
Ask AI
Helpful
Bookmark
Share
View Full Paper